Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kairos Pharma (KAPA) Total Non-Current Liabilities (2024)

Historic Total Non-Current Liabilities for Kairos Pharma (KAPA) over the last 1 years, with Q4 2024 value amounting to $992000.0.

  • Kairos Pharma's Total Non-Current Liabilities changed N/A to $992000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $992000.0, marking a year-over-year change of. This contributed to the annual value of $992000.0 for FY2024, which is N/A changed from last year.
  • As of Q4 2024, Kairos Pharma's Total Non-Current Liabilities stood at $992000.0.
  • Kairos Pharma's Total Non-Current Liabilities' 5-year high stood at $1.7 million during Q3 2024, with a 5-year trough of $992000.0 in Q4 2024.